TY - JOUR
AU - R. Shah
AU - S. Hendrickson
AU - L. Fanucchi
AU - M. Lofwall
AU - T. Platt
AU - C. Rhudy
A1 - 
AD - Specialty Pharmacy and Infusion Services, UK HealthCare, Lexington, KY, USA.;Division of Infectious Disease, Center for Drug and Alcohol Research, University of Kentucky College of Medicine, Lexington, KY, USA.;Departments of Behavioral Science and Psychiatry, Center for Drug and Alcohol Research, University of Kentucky College of Medicine, Lexington, KY, USA.
AN - 36149825
BT - Am J Health Syst Pharm
C5 - Opioids & Substance Use
CP - 1
DA - Jan 1
DO - 10.1093/ajhp/zxac269
DP - NLM
IS - 1
JF - Am J Health Syst Pharm
LA - eng
PY - 2023
SN - 1079-2082
SP - e59
EP - e66+
ST - Utility of an integrated health system specialty pharmacy in provision of extended-release buprenorphine for patients with opioid use disorder
T1 - Utility of an integrated health system specialty pharmacy in provision of extended-release buprenorphine for patients with opioid use disorder
T2 - Am J Health Syst Pharm
TI - Utility of an integrated health system specialty pharmacy in provision of extended-release buprenorphine for patients with opioid use disorder
U1 - Opioids & Substance Use
U3 - 10.1093/ajhp/zxac269
VL - 80
VO - 1079-2082
Y1 - 2023
ER -